Biodyne Co., Ltd. (KOSDAQ:314930)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,350
-120 (-0.83%)
At close: Feb 6, 2026
0.91%
Market Cap427.11B -10.7%
Revenue (ttm)4.98B +9.0%
Net Income-78.64M
EPS-2.64
Shares Out29.76M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume229,322
Average Volume173,778
Open13,940
Previous Close14,470
Day's Range13,260 - 14,390
52-Week Range10,870 - 18,420
Beta1.45
RSI60.82
Earnings DateAug 14, 2025

About Biodyne

Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314930
Full Company Profile

Financial Performance

Financial Statements